Quantitative Systems Pharmacology (QSP) Summit Cambridge

Thursday, October 12th | Le Meridien Boston Cambridge

About the Event

The Quantitative Systems Pharmacology (QSP) Summit is a premier, free conference dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its sixth year, the QSP Summit is a one-day event featuring talks from key industry and academic researchers, a poster session, and networking time with peers.

QSP Summit Promotional Graphic

Featured Speakers

Jane Bai, PhD - Expert Regulatory Scientist at the U.S. Food and Drug Administration

Rajat Desikan, PhD - Director of Quantitative Clinical Pharmacology at GSK

Jennifer Fretland, PhD - Senior Director of DMPK at EQRx

Irina Kareva, PhD - Associate Director at EMD Serono

Lyndsey Meyer, PhD - Researcher at Pfizer

Fereshteh Nazari, PhD - Translational PK/PD Modeler at Takeda

Alex Pellerin, PhD - Director at Seismic Therapeutic

Tianjing (Kiko) Ren, PhD - Postdoctoral Fellow at University at Buffalo and GSK

Peter Sorger, PhD - Otto Krayer Professor of Systems Pharmacology at Harvard Medical School

Weirong Wang, PhD Senior Scientific Director at Janssen R&D, Johnson & Johnson

Start Time (ET) Event
8:30 AM

Breakfast and registration

9:00 AM

Opening remarks

9:15 AM

Alex Pellerin, PhD
Director at Seismic Therapeutic

"Preclinical modeling of an IgG cleaving enzyme: A solution to a unique problem”

9:45 AM

Lyndsey Meyer, PhD
Researcher at Pfizer

“Developing a QSP model to interrogate mitochondrial dysfunction for applications in heart failure”

10:15 AM

Fereshteh Nazari, PhD
Translational PK/PD Modeler at Takeda

"A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development"

10:45 AM

Break and poster session

11:15 AM

Jane Bai, PhD
Expert Regulatory Scientist at the U.S. Food and Drug Administration

"Role of quantitative systems pharmacology in model informed drug development"

11:45 AM

Lightning Talks
Two, ten-minute talks selected from abstract submissions

Taylor Eggertsen, Graduate Research Assistant at the University of Virginia

Narshini Gunputh, Intern at Takeda

12:05 PM

Lunch and poster session

1:00 PM

Weirong Wang, PhD
Senior Scientific Director at Janssen 

"Exploring Immune Cell Dynamics with QSP Modeling: Case Studies in SLE and CRS"

1:30 PM

Jennifer Fretland, PhD
Senior Director at EQRx

"Application of Model-Informed Drug Development in Early Discovery"

2:00 PM

Break and poster session

2:30 PM

Rajat Desikan, PhD
Director, Quantitative Clinical Pharmacology at GSK

Tianjing (Kiko) Ren, PhD
Postdoctoral Fellow at GSK and University of Buffalo

"QSP modeling of chronic Hepatitis B infection decodes the mechanistic underpinnings of differential functional cure rates with standard-of-care therapies"

3:00 PM

Irina Kareva, PhD
Associate Director at EMD Serono

"Minimally Sufficient Experimental Design using Identifiability Analysis"

3:30 PM

Peter Sorger, PhD
Otto Krayer Professor of Systems Pharmacology at Harvard Medical School

"Multimodal tissue imaging and machine learning to advance precision medicine"

4:00 PM

Roundtable Discussion

Fretland (EQRx), Kareva (EMD Serono), Meyer (Pfizer), Pellerin (Seismic Therapeutic), and Sorger (Harvard Medical School)

Moderated by John Burke, PhD, Co-founder, President and CEO at Applied BioMath

5:00 PM

Closing remarks and poster awards

5:15 PM

QSP Summit concludes